Allakos competitorsClear all

Allakos's top competitors include Vyriad, ALX Oncology, Sosei Heptares and Rome Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Allakos
Allakos
Allakos, a biopharmaceutical company, focuses on developing therapeutic antibodies targeting allergic, inflammatory, and proliferative diseases.
Vyriad
Vyriad
Vyriad is a company that develops a biopharmaceutical platform designed to cure cancer.
ALX Oncology
ALX Oncology
ALX Oncology is a company that develops protein-based therapeutics intended to help in cancer treatment.
Sosei Heptares
Sosei Heptares
Sosei Heptares is an international biopharmaceutical company focused on the design and development of new medicines originating from its proprietary GPCR-targeted StaR technology and structure-based drug design platform capabilities.
Rome Therapeutics
Rome Therapeutics
Rome Therapeutics is a company that develops therapies created to cure cancer and autoimmune diseases.
Founding Date
Founding Date
2012
Founding Date
2016
Founding Date
2015
Founding Date
1990
Founding Date
2020
Type
Type
Public
Type
Private
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Redwood City, US HQ
Locations
Rochester, US HQ
Locations
Burlingame, US HQ
Dublin 2, IE
Locations
Chiyoda City, JP HQ
Great Abington, GB
London, GB
Locations
HQ
Cambridge, US
Employees
Employees
967% increase
Employees
366% increase
Employees
346% increase
Employees
1932% increase
Employees
313% increase
Valuation ($)
Valuation ($)
5.8 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
1.5 b
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
200
Twitter followers
2.4 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
76.5
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
259917
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
207171
Alexa Website Rank
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 24.4m (almost 2 years ago)
Latest funding round
$ 105m (over 1 year ago)
Latest funding round
N/A
Latest funding round
$ 50m (over 1 year ago)
Total funding raised
Total funding raised
N/A
Total funding raised
$ 24.4m
Total funding raised
$ 166m
Total funding raised
$ 65m
Total funding raised
$ 50m
For sources of this data, please see the company profile

View company profiles

Vyriad
HQ
Rochester, US
Employees
36↑ 6% increase

Vyriad is a company that develops a biopharmaceutical platform designed to cure cancer.

View company
ALX Oncology
HQ
Burlingame, US
Employees
34↑ 6% increase

ALX Oncology is a company that develops protein-based therapeutics intended to help in cancer treatment.

View company
Sosei Heptares
HQ
Chiyoda City, JP
Employees
193↑ 2% increase

Sosei Heptares is an international biopharmaceutical company focused on the design and development of new medicines originating from its proprietary GPCR-targeted StaR technology and structure-based drug design platform capabilities.

View company
Rome Therapeutics
HQ
Employees
31↑ 3% increase

Rome Therapeutics is a company that develops therapies created to cure cancer and autoimmune diseases.

View company